Older adults with diabetes and chronic kidney disease (CKD) are at an increased risk of cognitive impairment and dementia, frailty, dysglycemia, and polypharmacy.
Read More »Yearly Archives: 2019
Calories Burned Calculator
This calculator from Verywell Fit tells your patients how many calories they are burning according to the type of exercise they are performing and the length of time.
Read More »Testosterone Therapy in Hypogonadism Can Prevent Progression to T2DM
Men with prediabetes, hypogonadism achieved normal glucose regulation with TTh
Read More »E-Cigarettes May Threaten Goal of Achieving Tobacco Endgame
Concern increasing that use of newer tobacco products may catalyze transition to tobacco products, drugs
Read More »Resistance Training May Prevent Type 2 Diabetes Progression
Findings based on two-year comparison to aerobic training, no exercise among patients with prediabetes
Read More »March 12, 2019
Years ago, we only had a couple of drugs for diabetes and we wanted more. Then, in the past 10 years, we have had an explosion of drugs and you can bet there are more coming soon. This week, Joy Pape sits down with Jeffery Emmick from Eli Lilly to …
Read More »Probiotics Effects On Insulin Resistance
Probiotic supplements may be considered as an adjunct treatment for glycemic control in women who are pregnant and have gestational diabetes.
Read More »Gestational Diabetes Effects on Childhood Glucose Metabolism
Children of mothers with untreated gestational diabetes mellitus are at risk of insulin resistance and impairment in glucose metabolism.
Read More »Metformin Safety In Patients With Chronic Kidney Disease And Its Benefits
In patients with stage 3 kidney disease, metformin use may be safe and may reduce the risk of mortality and cardiovascular events.
Read More »Jeffrey Emmick 2018 Complete Interview
Jeffrey Emmick MD, Ph.D is the vice president of product development at Eli Lilly and Company. Dr. Emmick has been with the organization for over 20 years in various roles. Currently, he is responsible for late-stage clinical development for the entire Lilly diabetes portfolio.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.